Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00403377 · ClinicalTrials.gov registry record · Phase 1
Investigation of a Behavioral Substitute for Sunbathing
A Phase 1 study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- Phase 1
- Development phase
- 307
- Enrollment target
NCT00403377: Completed Phase 1 study, sponsored by University of Massachusetts, Worcester.
NCT00403377 is a Phase 1 study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 307 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (412% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00403377, a Phase 1 study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 307 participants
- Enrollment target
Study Summary
RATIONALE: Understanding why sunbathers use or don't use sunless tanning products may help doctors plan effective ways to prevent skin cancer caused by sunbathing. PURPOSE: This phase I/II trial is studying attitudes about the use of sunless tanning products and how well sunless tanning products work as a substitute for sunbathing in healthy participants.
Primary Outcome
The goal of the initial developmental phase of the present study is to determine the acceptability of sunless tanning as a substitute for sunbathing. Using focus groups comprised of sunbathers given the opportunity to sample sunless tanning products, we will identify perceived barriers and benefits of sunless tanning products, develop motivational messages encouraging the use of sunless tanning products, and preview intervention materials.
Interventions
- BEHAVIORAL Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 307 participants |
| Start Date | 2006-04 |
| Est. Completion | 2007-12 |
| Phase | Phase 1 |
What the finished NCT00403377 record still lists
NCT00403377 is an interventional study that assigns participants to a tested intervention. The registered 307 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (412% higher).
The record links to 0 conditions, and to 1 intervention - of which Intervention is the first listed.
NCT00403377 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00403377 about?
NCT00403377 is a clinical study titled "Investigation of a Behavioral Substitute for Sunbathing". RATIONALE: Understanding why sunbathers use or don't use sunless tanning products may help doctors plan effective ways to prevent skin cancer caused by sunbathing. PURPOSE: This phase I/II trial is studying attitudes about the use of sunless tanning products and how well sunless tanning products wo...
What is the current status of trial NCT00403377?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 307 participants. The study started on 2006-04. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00403377?
The interventions under investigation include: Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00403377?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00403377's enrollment target sits among peer trials
307 124th of 2000 higher than 1,877 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05433142 · 307 participants · Phase 1
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- NCT04162938 · 308 participants · NA
Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum
- NCT04955795 · 308 participants · NA
Telemedicine for Unhealthy Alcohol Use in Persons Living With HIV Using CETA
- NCT06090539 · 308 participants · Phase 1
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia